Abnormal Angiogenesis in Diabetic Nephropathy
Open Access
- 1 July 2009
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 58 (7), 1471-1478
- https://doi.org/10.2337/db09-0119
Abstract
No abstract availableThis publication has 76 references indexed in Scilit:
- Lowering Blood Pressure Blocks Mesangiolysis and Mesangial Nodules, but Not Tubulointerstitial Injury, in Diabetic eNOS Knockout MiceThe American Journal of Pathology, 2009
- Angiopoietin 2 Is a Partial Agonist/Antagonist of Tie2 Signaling in the EndotheliumMolecular and Cellular Biology, 2009
- Angiostatin overexpression is associated with an improvement in chronic kidney injury by an anti-inflammatory mechanismAmerican Journal of Physiology-Renal Physiology, 2009
- Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic miceProceedings of the National Academy of Sciences of the United States of America, 2008
- VEGF-A splicing: the key to anti-angiogenic therapeutics?Nature Reviews Cancer, 2008
- Inducible Overexpression of sFlt-1 in Podocytes Ameliorates Glomerulopathy in Diabetic MiceDiabetes, 2008
- VEGF Inhibition and Renal Thrombotic MicroangiopathyThe New England Journal of Medicine, 2008
- Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditionsProceedings of the National Academy of Sciences of the United States of America, 2007
- Management of Diabetic RetinopathyJAMA, 2007
- Mice expressing a humanized form of VEGF-A may provide insights into the safety and efficacy of anti-VEGF antibodiesProceedings of the National Academy of Sciences of the United States of America, 2007